Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page
- Check4 days agoChange DetectedThe study record history now shows a new revision (v3.4.1) replacing the previous revision (v3.4.0), and a government funding lapse notice is displayed on the page.SummaryDifference0.7%

- Check11 days agoChange DetectedA glossary toggle is added, diff highlights are color-coded (green for additions, red for deletions), and the revision label updates to v3.4.0.SummaryDifference0.9%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew history entry added: Revision: v3.3.4 appears in the Record History alongside prior revisions.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check75 days agoChange DetectedNew revision label v3.3.2 appears in the Record History, replacing the previous v3.2.0. This seems to be a routine site update and does not alter study data or core page content.SummaryDifference0.1%

- Check82 days agoChange DetectedThe funding-status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.